Vimarsana
Biggest News Aggregation in the World

Next Test News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Next Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Next Test Today - Breaking & Trending Today

Hillsdale Investment Management Inc. Has $3.69 Million Stock Position in Guardant Health, Inc. (NASDAQ:GH) - Vimarsana News

Hillsdale Investment Management Inc. Has $3.69 Million Stock Position in Guardant Health, Inc. (NASDAQ:GH)

Hillsdale Investment Management Inc. lessened its position in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 6.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 136,380 shares of the company’s stock after selling 9,720 shares during the quarter. Hillsdale Investment […]

Guardant Health (GH) Set to Announce Quarterly Earnings on Thursday - Vimarsana News

Guardant Health (GH) Set to Announce Quarterly Earnings on Thursday

Guardant Health (NASDAQ:GH – Get Free Report) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.72) per share for the quarter. Guardant Health has set its FY 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can […]

Mach 1 Financial Group LLC Has $437,000 Stake in Guardant Health, Inc. (NASDAQ:GH) - Vimarsana News

Mach 1 Financial Group LLC Has $437,000 Stake in Guardant Health, Inc. (NASDAQ:GH)

Mach 1 Financial Group LLC cut its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 15.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 16,160 shares of the company’s stock after selling 2,916 shares during the quarter. Mach 1 Financial […]

Source: wkrb13.com
Guardant Health (NASDAQ:GH) Price Target Cut to $30.00 - Vimarsana News

Guardant Health (NASDAQ:GH) Price Target Cut to $30.00

Guardant Health (NASDAQ:GH – Get Free Report) had its price objective dropped by research analysts at Canaccord Genuity Group from $45.00 to $30.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside […]

Canaccord Genuity Group Cuts Guardant Health (NASDAQ:GH) Price Target to $30.00 - Vimarsana News

Canaccord Genuity Group Cuts Guardant Health (NASDAQ:GH) Price Target to $30.00

Guardant Health (NASDAQ:GH – Get Free Report) had its price target lowered by stock analysts at Canaccord Genuity Group from $45.00 to $30.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price would indicate a potential upside of 64.93% from […]